Evidence map›Paper›PMID 29940173›Full record

ArticleBiochemical pharmacology2018

Pharmacological characterization of the neurotrophic sesquiterpene jiadifenolide reveals a non-convulsant signature and potential for progression in neurodegenerative disease studies.

Jeffrey M Witkin, Ryan A Shenvi, Xia Li, Scott D Gleason, Julie Weiss, Denise Morrow, John T Catow, Mark Wakulchik, Masaki Ohtawa, Hai-Hua Lu and 5 more

Open access · greenAbstract read
In one paragraph

Article in Biochemical pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Neurotrophic Natural Products.Progress in the chemistry of organic natural products · 2024
    Article
  3. Review
  4. Review
  5. Synthetic, Mechanistic, and Biological Interrogation ofJournal of the American Chemical Society · 2020
    Article
  6. Synthesis of (-)-Picrotoxinin by Late-Stage Strong Bond Activation.Journal of the American Chemical Society · 2020
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Jeffrey M WitkinThe Lilly Research Labs, Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: witkinconsult@gmail.com.
Ryan A ShenviDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA, USA.
Xia LiThe Lilly Research Labs, Eli Lilly and Company, Indianapolis, IN, USA.
Scott D GleasonThe Lilly Research Labs, Eli Lilly and Company, Indianapolis, IN, USA.
Julie WeissThe Lilly Research Labs, Eli Lilly and Company, Indianapolis, IN, USA.
Denise MorrowThe Lilly Research Labs, Eli Lilly and Company, Indianapolis, IN, USA.
John T CatowThe Lilly Research Labs, Eli Lilly and Company, Indianapolis, IN, USA.
Mark WakulchikThe Lilly Research Labs, Eli Lilly and Company, Indianapolis, IN, USA.
Masaki OhtawaDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA, USA.
Hai-Hua LuDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA, USA.
Michael D MartinezDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA, USA.
Jeffrey M SchkeryantzThe Lilly Research Labs, Eli Lilly and Company, Indianapolis, IN, USA.
Timothy S CarpenterBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA, USA.
Felice C LightstoneBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA, USA.
Rok CerneThe Lilly Research Labs, Eli Lilly and Company, Indianapolis, IN, USA.
Eli Lilly (United States) · USScripps Research Institute · USLawrence Livermore National Laboratory · US

Funding

Unusual Pharmacophores and New Tools for Cross-CouplingR35GM122606 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI Ryan Ashok Shenvi · 2017 to 2026
$7.1M
NIGMS NIH HHS R35 GM122606NIMH NIH HHS HHSN271201300017C
6 · The paper itself

Abstract

The 'neurotrophic sesquiterpenes' refer to a group of molecules derived from the Illicium genus of flowering plant. They display neurotrophic effects in cultured neuron preparations and have been suggested to be cognitive enhancers and potential therapeutics for neurodegenerative disorders and dementias. Recent synthetic advances generated sufficient quantities of jiadifenolide for in vivo investigation into its biological effects. Jiadifenolide did not induce convulsions in mice nor did it enhance or diminish convulsions induced by pentylenetetrazole. Other negative allosteric modulators of GABA

Indexed as

Disease ProgressionAnimalsConvulsantsDose-Response Relationship, DrugHEK293 CellsHumansLocomotionMaleMiceNerve Growth FactorsNeurodegenerative DiseasesProtein BindingProtein Structure, SecondaryPsychomotor AgitationSesquiterpenesConvulsantsjiadifenolideNerve Growth FactorsSesquiterpenesBilobalideConvulsionsJiadifenolideNeurodegenerative disordersNeurotrophic

Identifiers

PMID29940173
PMCPMC6135676
OpenAlexW2809453394

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.